Related Experiment Video

Updated: Jul 28, 2026

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
10:24

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions

Published on: June 11, 2015

Platelet adhesiveness in myocardial infarction in relation to clinical course

S Bygdeman, H Eliasch

    Acta Medica Scandinavica
    |January 1, 1976
    PubMed

    Insights

    Platelet adhesiveness was elevated in patients experiencing acute chest pain who later developed myocardial infarction. Levels returned to normal within two months, showing no link to infarction severity or outcome.

    Area of Science:

    • Cardiology
    • Hematology
    • Thrombosis

    Background:

    • Platelet activation plays a crucial role in acute coronary syndromes.
    • Understanding platelet behavior during acute myocardial infarction is vital for risk stratification.

    Purpose of the Study:

    • To investigate changes in platelet adhesiveness in patients with acute chest pain.
    • To correlate platelet adhesiveness with the development and severity of myocardial infarction.

    Main Methods:

    • Prospective study of 86 patients admitted to a coronary care unit for acute chest pain.
    • Repeated measurements of ADP-induced and whole blood platelet adhesiveness.
    • Comparison between patients with and without myocardial infarction, and healthy controls.

    Main Results:

    • Significantly increased platelet adhesiveness on admission in patients who developed myocardial infarction (Group 1) compared to others (Group 2) and controls (Group 3).
    • A secondary rise in platelet adhesiveness during the first week post-admission in Groups 1 and 2.
    • Platelet adhesiveness normalized within two months in all patient groups.
    • No significant correlation found between platelet adhesiveness and infarction size or patient outcome.
    • No difference in platelet adhesiveness between transmural and subendocardial infarction.

    Conclusions:

    • Elevated platelet adhesiveness is an early indicator in patients with acute chest pain who develop myocardial infarction.
    • Platelet adhesiveness normalizes over time, suggesting a transient role in the acute phase.
    • Platelet adhesiveness does not predict infarction severity or prognosis in this cohort.

    More Related Videos

    An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers05:43

    An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers

    Published on: November 8, 2024

    Microfluidics in Assessing Platelet Function06:47

    Microfluidics in Assessing Platelet Function

    Published on: November 8, 2024

    Related Concept Videos

    Intracellular Signaling Affects Focal Adhesions01:17

    Intracellular Signaling Affects Focal Adhesions

    Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
    Some...
    Formation of the Platelet Plug01:22

    Formation of the Platelet Plug

    The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
    As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
    Clot Retraction and Fibrinolysis01:16

    Clot Retraction and Fibrinolysis

    After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
    Myocarditis I: Introduction01:21

    Myocarditis I: Introduction

    Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
    Coronary Artery Disease II: Pathophysiology01:26

    Coronary Artery Disease II: Pathophysiology

    Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
    Acute Coronary Syndrome I: Introduction01:30

    Acute Coronary Syndrome I: Introduction

    Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...